81022-34-6 Usage
Derivative of triazole and carboxylic acid
The compound is formed by modifying the structure of triazole and carboxylic acid, which gives it its unique properties.
Antimicrobial and antitumor potential
The compound has shown to have inhibitory effects on certain enzymes, making it a potential candidate for use in antimicrobial and antitumor treatments.
Used in pharmaceutical and medicinal research
The compound is often used in the development of new drugs and treatments due to its unique properties and potential for further development.
Promising candidate for drug discovery
The structure and properties of the compound make it a promising candidate for further research in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 81022-34-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,0,2 and 2 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 81022-34:
(7*8)+(6*1)+(5*0)+(4*2)+(3*2)+(2*3)+(1*4)=86
86 % 10 = 6
So 81022-34-6 is a valid CAS Registry Number.
81022-34-6Relevant articles and documents
N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
-
, (2008/06/13)
NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.
